Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome. | Fam Cancer | 2024 | 39546056 | PubTator, text mining | PubMed |
| Germline Variants in DNA Interstrand-Cross Link Repair Genes May Contribute to Increased Susceptibility for Serrated Polyposis Syndrome. | Int J Mol Sci | 2024 | 39519399 | PubTator, text mining | PubMed |
| Analysis of actionable gene fusions in a large cohort of Chinese patients with colorectal cancer. | Gastroenterol Rep (Oxf) | 2024 | 39391592 | PubTator, text mining | PubMed |
| Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. | EBioMedicine | 2024 | 39383608 | PubTator, text mining | PubMed |
| Prognostic determinants in cancer survival: a multidimensional evaluation of clinical and genetic factors across 10 cancer types in the participants of Genomics England's 100,000 Genomes Project. | Discov Oncol | 2024 | 39277826 | PubTator, text mining | PubMed |
| TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases. | Heliyon | 2024 | 39258211 | PubTator, text mining | PubMed |
| Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration. | Cancer Immunol Immunother | 2024 | 39235609 | PubTator, text mining | PubMed |
| An "R-spondin code" for multimodal signaling ON-OFF states. | Bioessays | 2024 | 39180250 | PubTator, text mining | PubMed |
| RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy. | J Gene Med | 2024 | 39146560 | PubTator, text mining | PubMed |
| Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. | Int J Mol Sci | 2024 | 39126005 | PubTator, text mining | PubMed |
| New Target(s) for RNF43 Regulation: Implications for Therapeutic Strategies. | Int J Mol Sci | 2024 | 39125653 | PubTator, text mining | PubMed |
| Hereditary Colorectal Cancer and Polyposis Syndromes Caused by Variants in Uncommon Genes. | Genes Chromosomes Cancer | 2024 | 39120161 | PubTator, text mining | PubMed |
| Molecular pathogenesis of microsatellite instability-high early-stage colorectal adenocarcinoma in India. | Drug Metab Pers Ther | 2024 | 39042905 | PubTator, text mining | PubMed |
| Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status. | Invest Ophthalmol Vis Sci | 2024 | 39042403 | PubTator, text mining | PubMed |
| Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas. | Exp Mol Pathol | 2024 | 39033589 | PubTator, text mining | PubMed |
| Welcoming the new, revisiting the old: a brief glance at cytopathology reporting systems for lung, pancreas, and thyroid. | J Pathol Transl Med | 2024 | 39026441 | PubTator, text mining | PubMed |
| Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. | J Transl Med | 2024 | 38982444 | PubTator, text mining | PubMed |
| E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. | Life Sci Alliance | 2024 | 38969364 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis. | Hepatol Commun | 2024 | 38967597 | PubTator, text mining | PubMed |
| An novel effective and safe model for the diagnosis of nonalcoholic fatty liver disease in China: gene excavations, clinical validations, and mechanism elucidation. | J Transl Med | 2024 | 38965537 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=7